The Principles of MiRNA-Masking Antisense Oligonucleotides Technology

Methods in Molecular Biology

Volumn 676, Issue , 2011, Pages 43-49

  Wang, Zhiguo ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Anti miRNA antisense; Gene expression; MiRNA masking antisense oligonucleotides; MiRNAs

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA;

ANIMAL; ARTICLE; GENETICS; HUMAN;

ANIMALS; HUMANS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE;

MLCS; MLOWN;

EID: 79952201745     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-863-8_3     Document Type: Chapter

References (18)

1. Stenvang J, Kauppinen S (2008) MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 8:59–81.
2. Watanabe Y, Tomita M, Kanai A (2007) Computational methods for microRNA target prediction. Meth Enzymol 427:65–86.
3. Hutvágner G, Simard MJ, Mello CC, Zam PD (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2:465–475.
4. Meister G, Landthaler M, Dorsett Y, Tuschl T (2004) Sequence-specific inhibition of microRNA-and siRNA-induced RNA silencing. RNA 10:544–550.
5. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with “antagomirs”. Nature 438:685–689.
6. Lu Y, Xiao J, Lin H, Bai Y, Luo X, Wang Z, Yang B (2009) Complex antisense inhibitors offer a superior approach for microRNA research and therapy. Nucleic Acids Res 37:e24–e33.
7. Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721–726.
8. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033.
9. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994–9000.
10. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007) miR-21-mediated tumor growth. Oncogene 26:2799–1803.
11. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328–14336.
12. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miR-NAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290–1297.
13. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 100:1579–1588.
14. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128–2136.
15. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026–1033.
16. Choi WY, Giraldez AJ, Schier AF (2007) Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science 318:271–274.
17. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 212:285–292.
18. Wang Z, Luo X, Lu Y, Yang B (2008) MiRNAs at the heart of the matter. J Mol Med 86:772–783.